"We expect this vaccine to be more suited to the contexts in which it will be used, with fewer storage constraints and at a lower price.@MedsPatentPool will manage the intellectual property, and where necessary issue licences to manufacturers."-@DrTedroshttps://t.co/ITAAWY861L— World Health Organization (WHO) (@WHO) February 11, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


